Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P61278 (
somatostatin
)
22,083
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The neuronal scaffold protein
p140Cap
was investigated during hippocampal network formation.
p140Cap
is present in presynaptic GABAergic terminals and its genetic depletion results in a marked alteration of inhibitory synaptic activity.
p140Cap
-/- cultured neurons display higher frequency of miniature inhibitory postsynaptic currents (mIPSCs) with no changes of their mean amplitude. Consistent with a potential presynaptic alteration of basal GABA release,
p140Cap
-/- neurons exhibit a larger synaptic vesicle readily releasable pool, without any variation of single GABAA receptor unitary currents and number of postsynaptic channels. Furthermore,
p140Cap
-/- neurons show a premature and enhanced network synchronization and appear more susceptible to 4-aminopyridine-induced seizures in vitro and to kainate-induced seizures in vivo. The hippocampus of
p140Cap
-/- mice showed a significant increase in the number of both inhibitory synapses and of parvalbumin- and
somatostatin
-expressing interneurons. Specific deletion of
p140Cap
in forebrain interneurons resulted in increased susceptibility to in vitro epileptic events and increased inhibitory synaptogenesis, comparable to those observed in
p140Cap
-/- mice. Altogether, our data demonstrate that
p140Cap
finely tunes inhibitory synaptogenesis and GABAergic neurotransmission, thus regulating the establishment and maintenance of the proper hippocampal excitatory/inhibitory balance.
...
PMID:p140Cap Regulates GABAergic Synaptogenesis and Development of Hippocampal Inhibitory Circuits. 2916 54